Glucose-stimulated insulin secretion and -cell growth are important facets of pancreatic islet -cell biology. As a result, factors that modulate these processes are of great interest for the potential treatment of Type 2 diabetes. Here, we present evidence that the heterotrimeric G protein G z and its effectors, including some previously thought to be confined in expression to neuronal cells, are present in pancreatic -cells, the largest cellular constituent of the islets of Langerhans. Furthermore, signaling pathways upon which G␣ z impacts are intact in -cells, and G␣ z activation inhibits both cAMP production and glucose-stimulated insulin secretion in the Ins-1(832/13) -cell-derived line. Inhibition of glucose-stimulated insulin secretion by prostaglandin E (PGE1) is pertussis-toxin insensitive, indicating that other G␣ i family members are not involved in this process in this -cell line. Indeed, overexpression of a selective deactivator of G␣ z , the RGS domain of RGSZ1, blocks the inhibitory effect of PGE1 on glucosestimulated insulin secretion. Finally, the inhibition of glucose-stimulated insulin secretion by PGE1 is substantially blunted by small interfering RNA-mediated knockdown of G␣ z expression. Taken together, these data strongly imply that the endogenous E prostanoid receptor in the Ins-1(832/13) -cell line couples to G z predominantly and perhaps even exclusively. These data provide the first evidence for G z signaling in pancreatic -cells, and identify an endogenous receptormediated signaling process in -cells that is dependent on G␣ z function.Pancreatic islet -cells are the sole producers of insulin in the body and thus play an important homeostatic role in the secretion of insulin in response to glucose and other secretagogues. Normally, the release of insulin from -cells induces the peripheral tissues to take up available glucose from the plasma. Disregulation of this process can lead to the development of Type 2 diabetes, wherein the -cells are unable to compensate for peripheral tissue insulin resistance, either through inadequate -cell function and/or a decrease in -cell mass (1).Certain hormones such as norepinephrine, somatostatin, galanin, and E prostaglandins decrease the secretion of insulin from -cells in response to glucose (2). Pretreatment of pancreatic islet preparations with pertussis toxin (PTX) 1 alleviates the inhibitory effects of some of these hormones, leading to the original description of PTX as islet-activating protein (3). PTX catalyzes the ADP-ribosylation of a cysteine residue near the C terminus of nearly all G␣ subunits of the G␣ i subfamily (4), suggesting that the inhibition of glucose-stimulated insulin secretion (GSIS) is mediated by G␣ i proteins. However, several reports indicate a lack of effect, or only a partial effect, of PTX pretreatment on inhibition of insulin secretion in islets (5-8). This phenomenon of PTX insensitivity has been suggested to be because of insufficient PTX or too short a period of exposure (2), although an alternativ...